Cover Image

Extrapyramidal side effects with nonantipsychotic medications

Saved in:

Bibliographic Details
Main Authors:	Jessa Koch, PharmD, BCPP, APh (Author), Meljorie Launio, MD (Author), Andrew M. Williams, PharmD, BCPP (Author)
Format:	Book
Published:	American Association of Psychiatric Pharmacists, 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Management of OFF condition in Parkinson disease
by: Jessa Koch, PharmD, BCPP, APh
Published: (2023)

Do buprenorphine doses and ratios matter in medication assisted treatment adherence?
by: Kevin Kavanagh, PharmD, BCPP, et al.
Published: (2023)

Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
by: Kim Ehrhard, PharmD, BCPP, et al.
Published: (2023)

Effect of cannabis use on PTSD treatment outcomes in veterans
by: Meagan Petersen, PharmD, BCPP, et al.
Published: (2021)

Antidepressant prescribing in transgender and nonbinary individuals diagnosed with gender dysphoria and mood or anxiety disorders
by: Casey M. Tiefenthaler, PharmD, BCPP, et al.
Published: (2023)

Impact of traditional versus nontraditional initiation dosing schedule of paliperidone palmitate on 30-day readmission and safety
by: Erika Kim, PharmD, BCPP, et al.
Published: (2023)

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021)

Positioning psychiatric pharmacists to improve mental health care
by: Julie A. Dopheide, PharmD, BCPP, FASHP, et al.
Published: (2022)

Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
by: Hamad Mohammad Adam PharmD, BCPS, et al.
Published: (2023)

Barriers to access to psychiatric medications in Missouri county jails
by: Burval Jessica K. PharmD, BCPP, et al.
Published: (2023)

Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients
by: Danial Chowdhury, PharmD, et al.
Published: (2024)

A Veterans Affairs' perspective in response to Best Practice Model Subcommittee attribute statements for outpatient psychiatric pharmacists
by: Jonathan F. Lister, PharmD, BCPP, et al.
Published: (2022)

Survey of noncontrolled medication misuse patterns
by: Amelia Slane, PharmD, et al.
Published: (2022)

Training student pharmacists to administer long-acting injectable medications
by: Megan J. Ehret, PharmD, MS, BCPP, et al.
Published: (2024)

Psychotropic stewardship: Advancing patient care
by: Haight Robert J. PharmD, BCPP, et al.
Published: (2023)

COVID-19 reinfection in a patient with a serious mental illness within a long-term inpatient psychiatric care hospital
by: Brianna Englett, PharmD, BCPP, et al.
Published: (2021)

Pharmacologic management of adolescent catatonia: A dual-case series
by: Lauren Leiby, PharmD, BCPP, et al.
Published: (2024)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023)

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection
by: Trevor A. Stump, PharmD, BCPP, et al.
Published: (2021)

Survey of prescriptive authority among psychiatric pharmacists in the United States
by: Kelly C. Lee, PharmD, MAS, APh, BCPP, FCCP, et al.
Published: (2023)

Implementation and evaluation of interprofessional overdose review team recommendations following intentional or accidental overdose events
by: Monica Barrett, PharmD, BCPP, et al.
Published: (2024)

"It's been a long time since I drank like that": A case report of binge drinking associated with aripiprazole
by: Alyssa Falleni, PharmD, et al.
Published: (2024)

Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription
by: Kei Takamura, PharmD, BCPS, BCPP, et al.
Published: (2023)

Antipsychotic factors related to time to competency for forensic inpatients in a state psychiatric facility
by: Amber Lemons, PharmD, BCPP, et al.
Published: (2022)

Comparison of clozapine doses and tolerability in patients with and without concurrent valproic acid
by: Ranel Troy Santos, PharmD, BCPP, et al.
Published: (2023)

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
by: Richard J. Silvia, PharmD, BCPP, et al.
Published: (2022)

Comparison of inpatient psychiatric medication management in gender diverse youth with cisgender peers
by: Carrillo Nina PharmD, et al.
Published: (2023)

Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists
by: Amber R. Douglass, PharmD, BCPS, BCPP, et al.
Published: (2024)

Risperidone-induced angioedema
by: Caitlin Burton, PharmD, BCPP, et al.
Published: (2024)

Closing the gap: Raising medical professionals' transgender awareness and medical proficiency through pharmacist-led education
by: Ardsley P. Congdon III, PharmD, BCPS, BCPP, et al.
Published: (2021)

Publication rates and characteristics of PGY2 psychiatric pharmacy resident research projects
by: Dayton L. Antley, PharmD, BCPS, BCPP, et al.
Published: (2023)

Assessing the understandability, actionability, and quality of online resources for the self-management of bipolar disorder
by: Nathan D. Sutera, PharmD, et al.
Published: (2022)

Comment on "An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use"
by: Still Daniel PharmD, BCPP, et al.
Published: (2023)

Systematic literature review of the impact of psychiatric pharmacists
by: Jessica L. Ho, PharmD, BCPP, BCPS, et al.
Published: (2024)

Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
by: S. Andrea Laguado, PharmD, BCPS, BCPP, et al.
Published: (2023)

Assessment of oral overlap with antipsychotic long-acting injectables initiated in an inpatient setting
by: Tran Jennifer T. PharmD, et al.
Published: (2023)

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
by: Seema M. Patel, PharmD, BCPP, et al.
Published: (2021)

Pharmacist impact on medication reconciliation of behavioral health patients boarding in the emergency department
by: Mary Accomando, PharmD, BCPP, et al.
Published: (2022)

Terbinafine and risperidone drug interaction contributing to clinical changes in a forensic psychiatric patient
by: Reynolds Jamie PharmD, et al.
Published: (2023)

Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report
by: Menard Shannon PharmD, et al.
Published: (2021)